ImageneBio, Inc.
IMA
$8.35
$0.000.00%
NASDAQ
| 06/30/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | -38.11% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 8.30% | ||||
| Operating Income | -22.75% | ||||
| Income Before Tax | -24.81% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -24.81% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -24.81% | ||||
| EBIT | -22.75% | ||||
| EBITDA | -22.76% | ||||
| EPS Basic | -22,427.27% | ||||
| Normalized Basic EPS | -23,923.17% | ||||
| EPS Diluted | -22,427.27% | ||||
| Normalized Diluted EPS | -23,923.17% | ||||
| Average Basic Shares Outstanding | -99.48% | ||||
| Average Diluted Shares Outstanding | -99.48% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||